FRESENIUS KABI MALAYSIA SDN BHD — Carboplatin Importer Profile
Pharmaceutical Importer · #14 buyer for Carboplatin · $718.6K import value · 24 shipments · MALAYSIA · DGFT Verified
FRESENIUS KABI MALAYSIA SDN BHD is the #14 importer of Carboplatin from India with $718.6K in import value and 24 verified shipments. FRESENIUS KABI MALAYSIA SDN BHD holds a 1.0% market share in Carboplatin imports based in MALAYSIA. The company sources from 1 verified supplier across 19 formulations shipped to 1 country. Overall, FRESENIUS KABI MALAYSIA SDN BHD imports 8 pharmaceutical products worth $3.5M across 2 therapeutic categories.
FRESENIUS KABI MALAYSIA SDN BHD — Carboplatin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Carboplatin to FRESENIUS KABI MALAYSIA SDN BHD?
Verified from 24 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED | $718.6K | 24 | 100.0% |
FRESENIUS KABI MALAYSIA SDN BHD sources Carboplatin from 1 verified Indian supplier based on 24 customs records. The primary supplier is FRESENIUS KABI ONCOLOGY LIMITED accounting for 100.0% of imports.
How Does FRESENIUS KABI MALAYSIA SDN BHD Compare to Nearest Carboplatin Importers?
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | MULTICARE PHARMACEUTICALS PHILIPPIN | PHILIPPINES | $786.8K | 16 | $49.2K |
| 8 | FRESENIUS KABI COLOMBIA SAS | COLOMBIA | $750.0K | 15 | $50.0K |
| 14 | FRESENIUS KABI MALAYSIA SDN BHD ★ | MALAYSIA | $730.1K | 22 | $33.2K |
| 10 | ACCORD FARMA S A DE C V | MEXICO | $700.0K | 14 | $50.0K |
| 16 | FRESENIUS KABI TAIWAN LTD. | TAIWAN | $697.2K | 14 | $49.8K |
FRESENIUS KABI MALAYSIA SDN BHD ranks #14 among 829 Carboplatin importers from India. Average shipment value of $33.2K compared to the market average of $30.4K. The closest competitors by value are MULTICARE PHARMACEUTICALS PHILIPPIN and FRESENIUS KABI COLOMBIA SAS.
Where Does FRESENIUS KABI MALAYSIA SDN BHD Import Carboplatin To?
Destination countries from 24 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALAYSIA | $718.6K | 24 | 100.0% |
FRESENIUS KABI MALAYSIA SDN BHD imports Carboplatin to 1 country. The primary destination is MALAYSIA receiving 100.0% of shipments worth $718.6K.
What Carboplatin Formulations Does FRESENIUS KABI MALAYSIA SDN BHD Import?
| Formulation | Value | Shipments |
|---|---|---|
| KEMOCARB (CARBOPLATIN) BP INJ. 450MG/45M | $158.8K | 4 |
| KEMOCARB CARBOPLATIN BP INJ. 450MG/45M | $82.3K | 2 |
| KEMOCARB (CARBOPLATIN) BP INJ. 450MG/45ML VIAL BATCH NO. 87230472BB, MFG. DT. 11/2023, EXP. DT. 10/2025 | $50.0K | 1 |
| KEMOCARB (CARBOPLATIN) BP INJ. 450MG/45ML VIAL (BATCH NO. 87250083AA, MFG. DT. 03/2025, EXP. DT. 02/2027) | $50.0K | 1 |
| KEMOCARB (CARBOPLATIN) BP INJ. 150MG/15ML VIAL (BATCH NO. 87250068AC, MFG. DT. 03/2025, EXP. DT. 02/2027) | $48.3K | 1 |
| KEMOCARB CARBOPLATIN BP INJ 450MG 45ML VIAL BATCH NO 87250145AA MFG DT 04 2025 EXP DT 03 2027 | $46.4K | 1 |
| KEMOCARB (CARBOPLATIN) BP INJ. 450MG/45ML VIAL BATCH NO. 87230550AB MFG. DT. 12/2023 EXP. DT. 11/2025NOS | $45.1K | 1 |
| KEMOCARB (CARBOPLATIN) BP INJ. 450MG/45ML VIAL, BATCH NO. 87240101AC, MFG. DT. 03/2024, EXP. DT. 02/2026 | $44.0K | 1 |
| KEMOCARB (CARBOPLATIN) INJ. BP 450MG/45ML VIAL BATCH NO. 87230487AB, MFG. DT. 11/2023, EXP. DT. 10/2025 | $38.7K | 1 |
| KEMOCARB CARBOPLATIN BP INJ. 150MG/15M | $28.3K | 1 |
FRESENIUS KABI MALAYSIA SDN BHD imports 19 distinct Carboplatin formulations from India. The top formulation is KEMOCARB (CARBOPLATIN) BP INJ. 450MG/45M with 4 shipments worth $158.8K.
Who Are the Top Buyers of Carboplatin from India and How Much Does FRESENIUS KABI MALAYSIA SDN BHD Import?
India exported $25.2M worth of Carboplatin through 3,637 shipments from 273 suppliers to 138 countries, serving 829 buyers globally. FRESENIUS KABI MALAYSIA SDN BHD imports $718.6K of this total, accounting for 1.0% of India's Carboplatin exports with 24 shipments from MALAYSIA. This is verified from 24 customs shipment records covering 19 distinct formulations.
What Is the Average Order Value for FRESENIUS KABI MALAYSIA SDN BHD's Carboplatin Imports?
FRESENIUS KABI MALAYSIA SDN BHD's average Carboplatin order value is $29.9K per consignment, based on 24 shipments totaling $718.6K. FRESENIUS KABI MALAYSIA SDN BHD is based in MALAYSIA and ranks #14 among all Carboplatin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Carboplatin to FRESENIUS KABI MALAYSIA SDN BHD?
FRESENIUS KABI MALAYSIA SDN BHD sources Carboplatin from 1 verified Indian supplier: FRESENIUS KABI ONCOLOGY LIMITED ($718.6K, 100.0%). This is based on 24 customs records.
How Does FRESENIUS KABI MALAYSIA SDN BHD Compare to Other Carboplatin Importers?
FRESENIUS KABI MALAYSIA SDN BHD ranks #14 among 829 Carboplatin importers from India with a 1.0% market share. The top 3 importers are FRESENIUS KABI DEUTSCHLAND GMBH ($15.9M), EUGIA US LLC ($1.5M), EUGIA US LLC, ($1.3M). FRESENIUS KABI MALAYSIA SDN BHD processed 24 shipments from MALAYSIA.
What Other Oncology Products Does FRESENIUS KABI MALAYSIA SDN BHD Import?
FRESENIUS KABI MALAYSIA SDN BHD also imports these oncology products. Each links to the detailed product page.
About FRESENIUS KABI MALAYSIA SDN BHD
FRESENIUS KABI MALAYSIA SDN BHD imports 8 products worth $3.5M. Beyond Carboplatin, top products include Oxaliplatin, Docetaxel, Epirubicin, Gemcitabine, Cytarabine. View the complete FRESENIUS KABI MALAYSIA SDN BHD profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Carboplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Carboplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: FRESENIUS KABI MALAYSIA SDN BHD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as FRESENIUS KABI MALAYSIA SDN BHD's capped import value divided by total capped export value for Carboplatin across all Indian exporters.
- 5.Verified Records: This page is backed by 24 individual customs records matching FRESENIUS KABI MALAYSIA SDN BHD importing Carboplatin, covering 19 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 138+ countries, 829+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Carboplatin Import Data for FRESENIUS KABI MALAYSIA SDN BHD
Access order-level details, pricing data, supplier connections, and competitive analysis for FRESENIUS KABI MALAYSIA SDN BHD's Carboplatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FRESENIUS KABI MALAYSIA SDN BHD
Full Company Profile →
8 products · $3.5M total trade · 2 categories
FRESENIUS KABI MALAYSIA SDN BHD × Carboplatin
Verified from customs records
Company Overview
Top Products by FRESENIUS KABI MALAYSIA SDN BHD
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for FRESENIUS KABI MALAYSIA SDN BHD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Carboplatin. For current order-level data, contact TransData Nexus.